NASDAQLPCN
Year
View
Form | Description | Date | Format |
---|---|---|---|
10-K/A | Amendment to a previously filed 10-K | Apr 30, 2012 | ![]() ![]() ![]() ![]() |
10-K | Annual report which provides a comprehensive overview of the company for the past year | Mar 5, 2012 | ![]() ![]() ![]() ![]() |
We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.
Form | Description | Date | Format |
---|---|---|---|
10-K/A | Amendment to a previously filed 10-K | Apr 30, 2012 | ![]() ![]() ![]() ![]() |
10-K | Annual report which provides a comprehensive overview of the company for the past year | Mar 5, 2012 | ![]() ![]() ![]() ![]() |